Jagiellonian University Repository

The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC)

pcg.skipToMenu

The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC)

Bibliographic description

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)